Defunct Company
Total Trials
36
As Lead Sponsor
27
As Collaborator
9
Total Enrollment
5,986
NCT00212680
Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 1996
Completion: Not specified
NCT00046761
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
Phase: Phase 2/3
Start: Nov 30, 2002
NCT00083421
Effects of ONO-2506PO in Patients With Alzheimer's Disease
Start: Jun 30, 2004
Completion: Jul 31, 2007
NCT00212641
A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus
Start: Jun 30, 2005
NCT00335712
Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
Start: Jun 30, 2006
NCT00514865
Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
Start: Jun 13, 2007
Completion: Jun 30, 2008
NCT01253837
L19TNFα in Patients With Advanced Solid Tumors
Phase: Phase 1/2
Role: Collaborator
Start: Sep 30, 2007
Completion: Sep 30, 2011
NCT00532337
Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
Start: Oct 31, 2007
NCT01213732
Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma
Phase: Phase 1
Start: Oct 31, 2008
NCT00965978
A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation
Start: Jul 31, 2009
Completion: Sep 30, 2009
NCT01024231
Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
Start: Dec 14, 2009
Completion: Apr 1, 2019
NCT01081782
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Start: Mar 31, 2010
Completion: Dec 31, 2011
NCT01297582
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects
Start: Jan 31, 2011
NCT01345214
A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Start: May 31, 2011
NCT01364441
Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects
NCT01354431
BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
Completion: Apr 15, 2021
NCT01405651
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects
Start: Jul 31, 2011
NCT01358721
Phase I Biomarker Study (BMS-936558)
Start: Sep 23, 2011
Completion: May 22, 2019
NCT01489345
Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects
Start: Dec 31, 2011
NCT01508988
Single Dose Escalation Study of ONO-9054 in Healthy Volunteers
Start: Jan 31, 2012
NCT01536041
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
Start: Mar 31, 2012
NCT01551147
A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
Start: Jun 30, 2012
NCT01613703
ONO-2952 Single-dose PET Study in Healthy Adult Subjects
Start: Aug 31, 2012
NCT01670266
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
NCT01678690
An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
Phase: Early Phase 1
Completion: Apr 30, 2014
NCT01790607
An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment
Start: Feb 28, 2013
NCT01800630
Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas
Start: Apr 30, 2013
Completion: Mar 31, 2016
NCT01844180
A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT01887002
Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Start: Jun 30, 2013
NCT03568435
Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants
Phase: N/A
Start: Feb 14, 2018
Completion: Dec 21, 2020
NCT03569436
Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread
Completion: Jun 26, 2020
NCT03531320
Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase
Start: Aug 6, 2018
Completion: Dec 29, 2020
NCT05161325
A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan
Start: Dec 15, 2020
Completion: Jun 1, 2026
NCT05065957
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
Start: Mar 29, 2022
Completion: Dec 31, 2026
NCT05896215
OM202JP Clinical Study of KNP2002
Start: Jun 12, 2023
Completion: Jul 27, 2024
NCT06622057
D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Phase: Phase 3
Start: Jul 1, 2025
Completion: Dec 31, 2027